Octagon Capital Advisors »

Inozyme Pharma shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 400k 4.26
2023-09-30 $5.5M 1.3M 4.20
2023-06-30 $277k 50k 5.57